Předmět: |
|
Zdroj: |
Clinical Trials Week; 5/1/2023, p370-370, 1p |
Abstrakt: |
Keywords: Antimetabolites; Antineoplastics; Antipsoriatics; Antirheumatics; Arthritis; Autoimmune Diseases and Conditions; Bone Research; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Inflammation; Joint Diseases and Conditions; Methotrexate Therapy; Musculoskeletal Diseases and Conditions; Pharmaceuticals; Quality of Life; Rheumatoid Arthritis EN Antimetabolites Antineoplastics Antipsoriatics Antirheumatics Arthritis Autoimmune Diseases and Conditions Bone Research Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Inflammation Joint Diseases and Conditions Methotrexate Therapy Musculoskeletal Diseases and Conditions Pharmaceuticals Quality of Life Rheumatoid Arthritis 370 370 1 05/02/23 20230501 NES 230501 2023 MAY 1 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators publish new report on rheumatoid arthritis. Traditional Chinese medicine formula JuanBiQiangGu Granules (JBQG) are commonly used for the treatment of RA inflammation and delay of bone destruction, but has not been evaluated through high-quality clinical studies.". [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|